Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 550

1.

Interactions of multiple gene alterations in colorectal liver metastases.

Kawaguchi Y, Velasco JD, Arvide EM, Wei SH, Vauthey JN.

Chin Clin Oncol. 2019 Sep 3. pii: cco.2019.08.06. doi: 10.21037/cco.2019.08.06. [Epub ahead of print]

2.

Opioid-Prescribing Practices After Oncologic Surgery: Opportunities for Improvement and a Call to Action.

Newhook TE, Vreeland TJ, Dewhurst WL, Arvide EM, Bruno ML, Robinson KA, Rajkot N, Aloia TA, Katz MHG, Vauthey JN, Lee JE, Tzeng CD.

Ann Surg. 2019 Aug 29. doi: 10.1097/SLA.0000000000003595. [Epub ahead of print] No abstract available.

PMID:
31478982
3.

Development and validation of a risk score to predict the overall survival following surgical resection of hepatocellular carcinoma in non-cirrhotic liver.

Dasari BV, Kamarajah SK, Hodson J, Pawlik TM, Vauthey JN, Ma YT, Punia P, Coldham C, Abradelo M, Roberts KJ, Marudanayagam R, Sutcliffe RP, Muiesan P, Mirza DF, Isaac J.

HPB (Oxford). 2019 Aug 12. pii: S1365-182X(19)30621-5. doi: 10.1016/j.hpb.2019.07.007. [Epub ahead of print]

PMID:
31416786
4.

Gene mutation and surgical technique: Suggestion or more?

Kawaguchi Y, Lillemoe HA, Vauthey JN.

Surg Oncol. 2019 Jul 18. pii: S0960-7404(19)30291-9. doi: 10.1016/j.suronc.2019.07.004. [Epub ahead of print] Review.

PMID:
31351766
5.

Immunologic Correlates of Pathologic Complete Response to Preoperative Immunotherapy in Hepatocellular Carcinoma.

Kaseb AO, Vence L, Blando J, Yadav SS, Ikoma N, Pestana RC, Vauthey JN, Allison JP, Sharma P.

Cancer Immunol Res. 2019 Sep;7(9):1390-1395. doi: 10.1158/2326-6066.CIR-18-0605. Epub 2019 Jul 9.

PMID:
31289040
6.

Inpatient Opioid Use After Pancreatectomy: Opportunities for Reducing Initial Opioid Exposure in Cancer Surgery Patients.

Newhook TE, Dewhurst WL, Vreeland TJ, Wang X, Soliz J, Speer BB, Hancher-Hodges S, Feng C, Bruno ML, Kim MP, Aloia TA, Vauthey JN, Lee JE, Katz MHG, Tzeng CD.

Ann Surg Oncol. 2019 Oct;26(11):3428-3435. doi: 10.1245/s10434-019-07528-z. Epub 2019 Jun 26.

PMID:
31243665
7.

Mutation Status of RAS, TP53, and SMAD4 is Superior to Mutation Status of RAS Alone for Predicting Prognosis after Resection of Colorectal Liver Metastases.

Kawaguchi Y, Kopetz S, Newhook TE, De Bellis M, Chun YS, Tzeng CD, Aloia TA, Vauthey JN.

Clin Cancer Res. 2019 Jun 20. doi: 10.1158/1078-0432.CCR-19-0863. [Epub ahead of print]

PMID:
31221662
8.

Benefit of Gemcitabine/Nab-Paclitaxel Rescue of Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma After Early Failure of FOLFIRINOX.

Vreeland TJ, McAllister F, Javadi S, Prakash LR, Fogelman DR, Ho L, Varadhachary G, Aloia TA, Vauthey JN, Lee JE, Kim MP, Katz MHG, Tzeng CD.

Pancreas. 2019 Jul;48(6):837-843. doi: 10.1097/MPA.0000000000001345.

PMID:
31210666
9.

Treatment Options for Metastatic Gastrointestinal Stromal Tumors to the Liver: A Review.

Lillemoe HA, Brudvik KW, Vauthey JN.

Semin Liver Dis. 2019 Jul;39(3):395-402. doi: 10.1055/s-0039-1685517. Epub 2019 May 17.

PMID:
31100757
10.

Intraoperative Air Leak Test to Prevent Bile Leak After Right Posterior Sectionectomy with En Bloc Diaphragm Resection for Metastatic Teratoma.

Vreeland TJ, Beaudry Simoneau E, Dewhurst WL, Newhook TE, Westin SN, Mehran RJ, Chun YS, Aloia TA, Vauthey JN, Tzeng CD.

Ann Surg Oncol. 2019 Aug;26(8):2579. doi: 10.1245/s10434-019-07410-y. Epub 2019 May 7.

PMID:
31065963
11.

Conditional Recurrence-Free Survival after Resection of Colorectal Liver Metastases: Persistent Deleterious Association with RAS and TP53 Co-Mutation.

Kawaguchi Y, Lillemoe HA, Panettieri E, Chun YS, Tzeng CD, Aloia TA, Kopetz S, Vauthey JN.

J Am Coll Surg. 2019 Sep;229(3):286-294.e1. doi: 10.1016/j.jamcollsurg.2019.04.027. Epub 2019 May 2.

PMID:
31054911
12.

Guidelines Insights: Hepatobiliary Cancers, Version 2.2019.

Benson AB, D'Angelica MI, Abbott DE, Abrams TA, Alberts SR, Anaya DA, Anders R, Are C, Brown D, Chang DT, Cloyd J, Covey AM, Hawkins W, Iyer R, Jacob R, Karachristos A, Kelley RK, Kim R, Palta M, Park JO, Sahai V, Schefter T, Sicklick JK, Singh G, Sohal D, Stein S, Tian GG, Vauthey JN, Venook AP, Hammond LJ, Darlow SD.

J Natl Compr Canc Netw. 2019 Apr 1;17(4):302-310. doi: 10.6004/jnccn.2019.0019.

PMID:
30959462
13.

Educating Surgical Oncology Providers on Perioperative Opioid Use: Results of a Departmental Survey on Perceptions of Opioid Needs and Prescribing Habits.

Lillemoe HA, Newhook TE, Vreeland TJ, Arvide EM, Dewhurst WL, Grubbs EG, Aloia TA, Vauthey JN, Lee JE, Tzeng CD.

Ann Surg Oncol. 2019 Jul;26(7):2011-2018. doi: 10.1245/s10434-019-07321-y. Epub 2019 Apr 1.

PMID:
30937660
14.

Dealing with an insufficient future liver remnant: Portal vein embolization and two-stage hepatectomy.

Kawaguchi Y, Lillemoe HA, Vauthey JN.

J Surg Oncol. 2019 Apr;119(5):594-603. doi: 10.1002/jso.25430. Epub 2019 Mar 1. Review.

PMID:
30825223
15.

Is early-stage pancreatic adenocarcinoma truly early: stage migration on final pathology with surgery-first versus neoadjuvant therapy sequencing.

Lee AJ, Simoneau E, Chiang YJ, Lee JE, Kim MP, Aloia TA, Vauthey JN, Katz MH, Tzeng CD.

HPB (Oxford). 2019 Feb 21. pii: S1365-182X(19)30066-8. doi: 10.1016/j.hpb.2019.01.011. [Epub ahead of print]

PMID:
30799277
16.

Impact of epidural analgesia on the systemic biomarker response after hepatic resection.

Vicente D, Patino M, Marcus R, Lillmoe H, Limani P, Newhook T, Lee A, Tzeng CW, Segraves-Chun Y, Tweardy D, Gottumukkala V, Vauthey JN, Aloia T, Cata JP.

Oncotarget. 2019 Jan 15;10(5):584-594. doi: 10.18632/oncotarget.26549. eCollection 2019 Jan 15.

17.

Incidental versus non-incidental gallbladder cancer: index cholecystectomy before oncologic re-resection negatively impacts survival in T2b tumors.

Vega EA, Vinuela E, Okuno M, Joechle K, Sanhueza M, Diaz C, Jarufe N, Martinez J, Troncoso A, Diaz A, Chun YS, Tzeng CD, Lee JE, Vauthey JN, Conrad C.

HPB (Oxford). 2019 Aug;21(8):1046-1056. doi: 10.1016/j.hpb.2018.12.006. Epub 2019 Jan 31.

PMID:
30711243
18.

Positive cystic duct margin at index cholecystectomy in incidental gallbladder cancer is an important negative prognosticator.

Vega EA, Vinuela E, Sanhueza M, Mege R, Caracci M, Diaz C, Diaz A, Okuno M, Joechle K, Goumard C, Chun YS, Tzeng CD, Lee JE, Vauthey JN, Conrad C.

Eur J Surg Oncol. 2019 Jun;45(6):1061-1068. doi: 10.1016/j.ejso.2019.01.013. Epub 2019 Jan 24.

PMID:
30704808
19.

Circulating inflammation signature predicts overall survival and relapse-free survival in metastatic colorectal cancer.

Varkaris A, Katsiampoura A, Davis JS, Shah N, Lam M, Frias RL, Ivan C, Shimizu M, Morris J, Menter D, Overman M, Tran H, Heymach J, Chun YS, Vauthey JN, Calin G, Kopetz S.

Br J Cancer. 2019 Feb;120(3):340-345. doi: 10.1038/s41416-018-0360-y. Epub 2019 Jan 14.

PMID:
30636774
20.

Surgical margins and risk of local recurrence after wedge resection of colorectal pulmonary metastases.

Nelson DB, Tayob N, Mitchell KG, Correa AM, Hofstetter WL, Sepesi B, Walsh GL, Vaporciyan AA, Swisher SG, Antonoff MB, Roth JA, Rice DC, Vauthey JN, Mehran RJ.

J Thorac Cardiovasc Surg. 2019 Apr;157(4):1648-1655. doi: 10.1016/j.jtcvs.2018.10.156. Epub 2018 Nov 26.

PMID:
30635188
21.

Chemotherapy Versus Chemoradiation as Preoperative Therapy for Resectable Pancreatic Ductal Adenocarcinoma: A Propensity Score Adjusted Analysis.

Cloyd JM, Chen HC, Wang X, Tzeng CD, Kim MP, Aloia TA, Vauthey JN, Lee JE, Katz MHG.

Pancreas. 2019 Feb;48(2):216-222. doi: 10.1097/MPA.0000000000001231.

PMID:
30629022
22.

Contemporary analysis of complications associated with biliary stents during neoadjuvant therapy for pancreatic adenocarcinoma.

Kim BJ, Prakash L, Narula N, Davis CH, Kim MP, Aloia TA, Vauthey JN, Lee JE, Katz MH, Tzeng CD.

HPB (Oxford). 2019 Jun;21(6):662-668. doi: 10.1016/j.hpb.2018.10.009. Epub 2018 Dec 3.

PMID:
30522947
23.

Pancreaticoduodenectomy with Mesocaval Shunt for Locally Advanced Pancreatic Adenocarcinoma.

Simoneau E, Goumard C, Lee JE, Vauthey JN, Aloia TA, Chun YS, Kim MP, Katz MHG, Tzeng CD.

Ann Surg Oncol. 2019 Feb;26(2):652. doi: 10.1245/s10434-018-07093-x. Epub 2018 Dec 11.

PMID:
30539487
24.

Preoperative drainage for perihilar cholangiocarcinoma.

Odisio BC, Krampitz GW, Murthy R, Mahvash A, Javle M, Vauthey JN.

Lancet Gastroenterol Hepatol. 2019 Jan;4(1):10-11. doi: 10.1016/S2468-1253(18)30345-5. Epub 2018 Dec 6. No abstract available.

PMID:
30527574
25.

Perioperative blood transfusions for vein resection during pancreaticoduodenectomy for pancreatic adenocarcinoma: Identification of clinical targets for optimization.

Snyder RA, Prakash LR, Nogueras-Gonzalez GM, Kim MP, Aloia TA, Vauthey JN, Lee JE, Fleming JB, Katz MHG, Tzeng CD.

HPB (Oxford). 2019 Jul;21(7):841-848. doi: 10.1016/j.hpb.2018.10.018. Epub 2018 Nov 28.

PMID:
30501986
26.

Clinical Factors Associated With Practice Variation in Discharge Opioid Prescriptions After Pancreatectomy.

Newhook TE, Vreeland TJ, Dewhurst WL, Wang X, Prakash L, Feng C, Bruno ML, Kim MP, Aloia TA, Vauthey JN, Lee JE, Katz MHG, Tzeng CD.

Ann Surg. 2018 Nov 29. doi: 10.1097/SLA.0000000000003112. [Epub ahead of print]

PMID:
30499795
27.

Middle Hepatic Vein Roadmap for a Safe Laparoscopic Right Hepatectomy.

Joechle K, Vega EA, Okuno M, Simoneau E, Ogiso S, Newhook TE, Ramirez DL, Holmes AA, Soliz JM, Chun YS, Tzeng CD, Lee JE, Vauthey JN, Conrad C.

Ann Surg Oncol. 2019 Jan;26(1):296. doi: 10.1245/s10434-018-7034-0. Epub 2018 Nov 21.

PMID:
30465224
28.

ASO Author Reflections: RAS Mutations in Metastatic Colorectal Cancer.

Passot G, Vauthey JN, Chun YS.

Ann Surg Oncol. 2018 Dec;25(Suppl 3):850-851. doi: 10.1245/s10434-018-7020-6. Epub 2018 Nov 12. No abstract available.

PMID:
30421059
29.

Intrahepatic Recurrence Patterns Predict Survival After Resection of Colorectal Liver Metastases.

Lee AJ, Loyer EM, Kang HC, Aloia TA, Tzeng CD, Vauthey JN, Chun YS.

Ann Surg Oncol. 2019 Jan;26(1):275-281. doi: 10.1245/s10434-018-6945-0. Epub 2018 Oct 25.

PMID:
30362064
30.

Comprehensive Complication Index Validates Improved Outcomes Over Time Despite Increased Complexity in 3707 Consecutive Hepatectomies.

Cloyd JM, Mizuno T, Kawaguchi Y, Lillemoe HA, Karagkounis G, Omichi K, Chun YS, Conrad C, Tzeng CD, Odisio BC, Huang SY, Hicks M, Wei SH, Aloia TA, Vauthey JN.

Ann Surg. 2018 Oct 17. doi: 10.1097/SLA.0000000000003043. [Epub ahead of print]

PMID:
30339628
31.

ASO Author Reflections: Role of Preoperative Chemotherapy in the Treatment of Pancreatic Neuroendocrine Liver Metastases.

Tran Cao HS, Vauthey JN.

Ann Surg Oncol. 2018 Dec;25(Suppl 3):792-793. doi: 10.1245/s10434-018-6921-8. Epub 2018 Oct 17. No abstract available.

PMID:
30334195
32.

The Prognostic Impact of KRAS Mutation in Patients Having Curative Resection of Synchronous Colorectal Liver Metastases.

Goffredo P, Utria AF, Beck AC, Chun YS, Howe JR, Weigel RJ, Vauthey JN, Hassan I.

J Gastrointest Surg. 2018 Oct 1. doi: 10.1007/s11605-018-3978-4. [Epub ahead of print]

PMID:
30276588
33.

Conceptual framework of middle hepatic vein anatomy as a roadmap for safe right hepatectomy.

Ogiso S, Okuno M, Shindoh J, Sakamoto Y, Mizuno T, Araki K, Goumard C, Nomi T, Ishii T, Uemoto S, Chun YS, Tzeng CD, Lee JE, Vauthey JN, Conrad C.

HPB (Oxford). 2019 Jan;21(1):43-50. doi: 10.1016/j.hpb.2018.01.002. Epub 2018 Sep 25.

PMID:
30266496
34.

The role of preoperative therapy prior to pancreatoduodenectomy for distal cholangiocarcinoma.

Cloyd JM, Prakash L, Vauthey JN, Aloia TA, Chun YS, Tzeng CW, Kim MP, Lee JE, Katz MHG.

Am J Surg. 2019 Jul;218(1):145-150. doi: 10.1016/j.amjsurg.2018.08.024. Epub 2018 Sep 6.

PMID:
30224070
35.

Loss of muscle mass during preoperative chemotherapy as a prognosticator for poor survival in patients with colorectal liver metastases.

Okuno M, Goumard C, Kopetz S, Vega EA, Joechle K, Mizuno T, Tzeng CD, Chun YS, Lee JE, Vauthey JN, Aloia TA, Conrad C.

Surgery. 2019 Feb;165(2):329-336. doi: 10.1016/j.surg.2018.07.031. Epub 2018 Sep 6.

PMID:
30197278
36.

Comment on Letter to the Editor Regarding "ALPPS Improves Resectability Compared With Conventional Two-stage Hepatectomy in Patients With Advanced Colorectal Liver Metastasis: When Innovation is Not Enough".

Vega EA, Simoneau E, Tzeng CD, Odisio BC, Aloia TA, Chun YS, Vauthey JN.

Ann Surg. 2019 Aug;270(2):e35-e36. doi: 10.1097/SLA.0000000000003025. No abstract available.

PMID:
30169392
37.

Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinoma.

Elganainy D, Holliday EB, Taniguchi CM, Smith GL, Shroff R, Javle M, Raghav K, Kaseb A, Aloia TA, Vauthey JN, Tzeng CD, Herman JM, Koong AC, Krishnan SX, Minsky BD, Crane CH, Das P, Koay EJ.

Cancer Med. 2018 Oct;7(10):4880-4892. doi: 10.1002/cam4.1734. Epub 2018 Aug 27.

38.

Long-term survival after post-hepatectomy liver failure for colorectal liver metastases.

Joechle K, Goumard C, Vega EA, Okuno M, Chun YS, Tzeng CD, Vauthey JN, Conrad C.

HPB (Oxford). 2019 Mar;21(3):361-369. doi: 10.1016/j.hpb.2018.07.019. Epub 2018 Aug 9.

PMID:
30100391
39.

Validation of American Joint Committee on Cancer eighth staging system for gallbladder cancer and its lymphadenectomy guidelines.

Lee AJ, Chiang YJ, Lee JE, Conrad C, Chun YS, Aloia TA, Vauthey JN, Tzeng CD.

J Surg Res. 2018 Oct;230:148-154. doi: 10.1016/j.jss.2018.04.067. Epub 2018 May 31.

PMID:
30100032
40.

What Is the Best Pain Control After Major Hepatopancreatobiliary Surgery?

Kim BJ, Soliz JM, Aloia TA, Vauthey JN.

Adv Surg. 2018 Sep;52(1):235-246. doi: 10.1016/j.yasu.2018.03.002. Epub 2018 Jun 19. Review. No abstract available.

41.

Surgical Resection for Recurrence After Two-Stage Hepatectomy for Colorectal Liver Metastases Is Feasible, Is Safe, and Improves Survival.

Lillemoe HA, Kawaguchi Y, Passot G, Karagkounis G, Simoneau E, You YN, Mehran RJ, Chun YS, Tzeng CD, Aloia TA, Vauthey JN.

J Gastrointest Surg. 2019 Jan;23(1):84-92. doi: 10.1007/s11605-018-3890-y. Epub 2018 Aug 6.

PMID:
30084064
42.

Liver transplantation for locally advanced intrahepatic cholangiocarcinoma - Authors' reply.

Lunsford KE, Javle M, Gaber AO, Vauthey JN, Ghobrial RM.

Lancet Gastroenterol Hepatol. 2018 Aug;3(8):529-530. doi: 10.1016/S2468-1253(18)30167-5. No abstract available.

PMID:
30047444
43.

Minimally invasive management of the entire treatment sequence in patients with stage IV colorectal cancer: a propensity-score weighting analysis.

Goumard C, Nancy You Y, Okuno M, Kutlu O, Chen HC, Simoneau E, Vega EA, Chun YS, David Tzeng C, Eng C, Vauthey JN, Conrad C.

HPB (Oxford). 2018 Dec;20(12):1150-1156. doi: 10.1016/j.hpb.2018.05.011. Epub 2018 Jul 11.

PMID:
30005993
44.

R1 Resection for Colorectal Liver Metastases: a Survey Questioning Surgeons about Its Incidence, Clinical Impact, and Management.

ViganĂ² L, Costa G, Cimino MM, Procopio F, Donadon M, Del Fabbro D, Belghiti J, Kokudo N, Makuuchi M, Vauthey JN, Torzilli G.

J Gastrointest Surg. 2018 Oct;22(10):1752-1763. doi: 10.1007/s11605-018-3820-z. Epub 2018 Jun 8.

PMID:
29948554
45.

Reply to: Dissecting the therapeutic implications of the complex SMAD4 regulatory network in metastatic colorectal cancer.

Cloyd JM, Mizuno T, Vauthey JN.

Eur J Surg Oncol. 2018 Aug;44(8):1285. doi: 10.1016/j.ejso.2018.05.016. Epub 2018 May 18. No abstract available.

PMID:
29843938
46.

RAS Mutation is Associated with Unsalvageable Recurrence Following Hepatectomy for Colorectal Cancer Liver Metastases.

Okuno M, Goumard C, Kopetz S, Vega EA, Joechle K, Mizuno T, Omichi K, Tzeng CD, Chun YS, Vauthey JN, Conrad C.

Ann Surg Oncol. 2018 Aug;25(8):2457-2466. doi: 10.1245/s10434-018-6517-3. Epub 2018 May 21.

PMID:
29786130
47.

Fast-Track Two-Stage Hepatectomy Using a Hybrid Interventional Radiology/Operating Suite as Alternative Option to Associated Liver Partition and Portal Vein Ligation for Staged Hepatectomy Procedure.

Odisio BC, Simoneau E, Holmes AA, Conrad CH, Vauthey JN.

J Am Coll Surg. 2018 Aug;227(2):e5-e10. doi: 10.1016/j.jamcollsurg.2018.04.027. Epub 2018 May 4. No abstract available.

PMID:
29729926
48.

Vein resection during pancreaticoduodenectomy for pancreatic adenocarcinoma: Patency rates and outcomes associated with thrombosis.

Snyder RA, Prakash LR, Nogueras-Gonzalez GM, Kim MP, Aloia TA, Vauthey JN, Lee JE, Fleming JB, Katz MHG, Tzeng CD.

J Surg Oncol. 2018 Jun;117(8):1648-1654. doi: 10.1002/jso.25067. Epub 2018 May 3.

PMID:
29723419
49.

Prognostic impact of perihepatic lymph node metastases in patients with resectable colorectal liver metastases.

Okuno M, Goumard C, Mizuno T, Kopetz S, Omichi K, Tzeng CD, Chun YS, Lee JE, Vauthey JN, Conrad C.

Br J Surg. 2018 Aug;105(9):1200-1209. doi: 10.1002/bjs.10822. Epub 2018 Apr 17.

PMID:
29664996
50.

Preoperative Fluorouracil, Doxorubicin, and Streptozocin for the Treatment of Pancreatic Neuroendocrine Liver Metastases.

Cloyd JM, Omichi K, Mizuno T, Kawaguchi Y, Tzeng CD, Conrad C, Chun YS, Aloia TA, Katz MHG, Lee JE, Halperin D, Yao J, Vauthey JN, Dasari A.

Ann Surg Oncol. 2018 Jun;25(6):1709-1715. doi: 10.1245/s10434-018-6468-8. Epub 2018 Apr 6.

Supplemental Content

Loading ...
Support Center